Nitazene Control Act of 2025

# Nitazene Control Act of 2025 Summary **What the Bill Would Do** The Nitazene Control Act of 2025 would establish federal controls over nitazenes, a class of synthetic opioid drugs. Nitazenes are increasingly appearing in illicit drug supplies and have been linked to overdose deaths. By regulating these substances at the federal level, the bill aims to make it harder to manufacture, distribute, and possess nitazenes without authorization, similar to how other controlled substances like fentanyl are regulated. **Who It Affects and Key Provisions** The bill would primarily affect drug manufacturers, distributors, and law enforcement agencies. Anyone illegally producing or selling nitazenes could face federal criminal penalties.

The bill may also impact medical and research institutions that work with synthetic compounds, though legitimate medical or research use would likely be permitted under proper licensing. Healthcare providers and public health officials could benefit from having clearer legal tools to address nitazene-related overdoses. **Current Status** As of now, the bill (HR 5415) is in committee, meaning it has been introduced in the House but has not yet advanced to a full vote. It was sponsored by Representative Eugene Vindman (D-VA). The bill remains in the early stages of the legislative process and would need committee approval and a House vote before potentially moving to the Senate.